How should I evaluate and treat a patient with a serum sodium of 130 mEq/L?

Evaluation and Management of Serum Sodium 130 mEq/L

A serum sodium of 130 mEq/L represents mild hyponatremia that requires systematic evaluation to determine volume status and underlying etiology, followed by targeted treatment based on symptom severity and the specific cause identified. 1

Initial Diagnostic Workup

Obtain the following laboratory tests immediately to guide management:

• Serum osmolality to confirm hypotonic hyponatremia (expected <275 mOsm/kg) and exclude pseudohyponatremia from hyperglycemia or hyperlipidemia 1, 2
• Urine sodium concentration and urine osmolality to differentiate between causes: urine sodium <30 mmol/L suggests hypovolemic hyponatremia, while urine sodium >20-40 mmol/L with urine osmolality >300 mOsm/kg suggests SIADH 1, 3
• Serum creatinine and BUN to assess renal function and calculate BUN:Cr ratio (>20:1 suggests prerenal azotemia) 1
• Thyroid-stimulating hormone (TSH) to exclude hypothyroidism 1
• Morning cortisol or ACTH stimulation test to rule out adrenal insufficiency 1
• Serum uric acid (<4 mg/dL has 73-100% positive predictive value for SIADH) 1

Do not delay treatment while awaiting ADH or natriuretic peptide levels, as these tests add no clinical value and are not supported by evidence. 1

Volume Status Assessment

Physical examination is unreliable (sensitivity 41%, specificity 80%) but should focus on specific findings: 1

Hypovolemic Signs

• Orthostatic hypotension (>20 mmHg systolic drop or >10 mmHg diastolic drop upon standing) 1
• Dry mucous membranes and decreased skin turgor 1
• Flat neck veins and tachycardia 1

Euvolemic Signs

• Absence of both hypovolemic and hypervolemic findings 1
• Normal blood pressure without orthostatic changes 1

Hypervolemic Signs

• Peripheral edema, ascites, jugular venous distention 1
• Pulmonary congestion on examination 1

Treatment Based on Volume Status and Symptom Severity

Asymptomatic or Mildly Symptomatic (Nausea, Headache, Weakness)

Hypovolemic Hyponatremia

Administer isotonic saline (0.9% NaCl) for volume repletion at 15-20 mL/kg/h initially, then 4-14 mL/kg/h based on clinical response. 1 Discontinue any diuretics immediately if sodium <125 mmol/L. 1

Euvolemic Hyponatremia (SIADH)

Implement fluid restriction to 1 L/day as first-line treatment. 1, 4 If no response after 24-48 hours, add oral sodium chloride 100 mEq three times daily. 1 For resistant cases, consider vasopressin receptor antagonists (tolvaptan 15 mg once daily, titrate to 30-60 mg). 1, 5

Hypervolemic Hyponatremia (Heart Failure, Cirrhosis)

Implement fluid restriction to 1-1.5 L/day for sodium <125 mmol/L. 1 Temporarily discontinue diuretics if sodium drops below 125 mmol/L. 1 In cirrhotic patients, consider albumin infusion (8 g per liter of ascites removed) alongside fluid restriction. 1

Severe Symptomatic (Seizures, Altered Mental Status, Coma)

Administer 3% hypertonic saline immediately with a target correction of 6 mmol/L over 6 hours or until severe symptoms resolve. 1, 6 Give 100 mL boluses over 10 minutes, repeating up to three times at 10-minute intervals if needed. 1 Admit to ICU for close monitoring. 1

Critical Correction Rate Guidelines

The total correction must not exceed 8 mmol/L in any 24-hour period to prevent osmotic demyelination syndrome. 1, 7 This is the single most important safety principle in hyponatremia management.

High-Risk Patients Requiring Slower Correction (4-6 mmol/L per day maximum):

• Advanced liver disease or cirrhosis 1, 7
• Chronic alcoholism 1, 7
• Malnutrition 1, 7
• Prior hepatic encephalopathy 1
• Severe hyponatremia (<120 mmol/L) 1

Monitor serum sodium every 2 hours during initial correction of severe symptoms, then every 4-6 hours after symptom resolution. 1

Management of Overcorrection

If sodium rises >8 mmol/L in 24 hours, immediately discontinue current fluids and switch to D5W (5% dextrose in water). 1 Consider administering desmopressin to slow or reverse the rapid rise, with a goal of bringing total 24-hour correction back to ≤8 mmol/L from baseline. 1

Special Considerations

Neurosurgical Patients

Distinguish between SIADH and cerebral salt wasting (CSW), as they require opposite treatments. 1 CSW presents with true hypovolemia (CVP <6 cm H₂O) and requires volume and sodium replacement with isotonic or hypertonic saline, never fluid restriction. 1 In subarachnoid hemorrhage patients at risk of vasospasm, fluid restriction is contraindicated. 1

Medication Review

Review all medications for potential causes: SSRIs, carbamazepine, NSAIDs, opioids, chemotherapy agents (platinum-based, vinca alkaloids), and diuretics. 1

Common Pitfalls to Avoid

• Never correct chronic hyponatremia faster than 8 mmol/L in 24 hours—this causes osmotic demyelination syndrome (dysarthria, dysphagia, oculomotor dysfunction, quadriparesis typically 2-7 days after rapid correction). 1, 7
• Never use fluid restriction in cerebral salt wasting—this worsens outcomes and can precipitate cerebral ischemia. 1
• Never ignore mild hyponatremia (130-135 mmol/L)—it is associated with increased mortality (60-fold increase at <130 mmol/L), falls (21% vs 5% in normonatremic patients), and attention deficits. 1
• Never use hypertonic saline in hypervolemic hyponatremia without life-threatening symptoms—it worsens ascites and edema. 1
• Never rely on physical examination alone for volume assessment—supplement with laboratory parameters (urine sodium, BUN:Cr ratio, central venous pressure when available). 1